"
Team:UFAM Brazil/7-5-2014
From 2014.igem.org
Manickchand (Talk | contribs) |
Manickchand (Talk | contribs) |
||
| Line 78: | Line 78: | ||
</td></tr> | </td></tr> | ||
| - | <tr><td colspan="3" align="center"><p>JM110 – Trial with <i>Ampicylin 50 ug/ml 100 ug/ml | + | <tr><td colspan="3" align="center"><p>JM110 – Trial with <i>Ampicylin 50 ug/ml 100 ug/ml</i>:</p> |
</td></tr> | </td></tr> | ||
<tr><td colspan="3" align="center"> | <tr><td colspan="3" align="center"> | ||
<img src="https://static.igem.org/mediawiki/2014/c/cf/UFAM_Brazil_2014_7-5-20148.jpg" width="300"> | <img src="https://static.igem.org/mediawiki/2014/c/cf/UFAM_Brazil_2014_7-5-20148.jpg" width="300"> | ||
| - | </td></tr | + | </td></tr> |
| + | |||
| + | <tr><td colspan="3" align="center"><p>JM110 – Trial with <i>Kanamycin: 25 ug/ml and 50 ug/ml</i>:</p> | ||
| + | </td></tr> | ||
| + | |||
| + | <tr><td colspan="3" align="center"> | ||
| + | <img src="https://static.igem.org/mediawiki/2014/c/c6/UFAM_Brazil_2014_7-5-20149.jpg" width="300"> | ||
| + | </td></tr> | ||
| + | |||
| + | <tr><td colspan="3" align="center"><p>JM110 – Trials with <i>chloramphenicol: 34 ug/ml and 68 ug/ml</i>:</p> | ||
| + | </td></tr> | ||
| + | |||
| + | <tr><td colspan="3" align="center"> | ||
| + | <img src="https://static.igem.org/mediawiki/2014/2/2e/UFAM_Brazil_2014_7-5-201410.jpg" width="300"> | ||
| + | </td></tr> | ||
| + | |||
| + | <tr><td colspan="3" ><p>Today we also cryopreserved the bacteria with glycerol and we inoculated LB soft medium to store them.</p> | ||
| + | <p> We transformed using the Transformation Protocol using Sorbitol in the li <i>E. coli</i> JM110 e ERC2925 lines with the pUC72 plasmid. </p> | ||
| + | </td></tr> | ||
| + | |||
| + | |||
Revision as of 18:47, 24 September 2014
07/04/2014 | |||||||||
Results with the antibiotics tests: | |||||||||
|
Legend Green: it grew. Yellow: It didn’t grow at a good amount Red: It didn’t grow |
||||||||
Pictures of our trials using antibiotic in the JM110 e ERC2925 E.coli lines ER5C2925 – Trial with Streptomycin, in order: 20 ug/ml, 40 ug/ml, 100 ug/ml and 150 ug/ml: | |||||||||
| |||||||||
ER5C2925 – Trials with Ampicillin: 50ug/ml and100ug/ml: | |||||||||
| |||||||||
ER5C2925 – Trials with Tetracycline : 12 ug/ml and 24 ug/ml: | |||||||||
| |||||||||
ER5C2925 – Trials with Kanamycin: 25 ug/ml e 50 ug/ml: | |||||||||
| |||||||||
ER5C2925 – Trials with Chloramphenicol: 34 ug/ml and 68 ug/ml: | |||||||||
| |||||||||
JM110 – Trials with Streptomycin: 20 ug/ml, 40 ug/ml, 100 ug/ml and 150 ug/ml: | |||||||||
| |||||||||
JM110 – Trials with Tetraciclyn:12 ug/ml e 24 ug/ml: | |||||||||
| |||||||||
JM110 – Trial with Ampicylin 50 ug/ml 100 ug/ml: | |||||||||
| |||||||||
JM110 – Trial with Kanamycin: 25 ug/ml and 50 ug/ml: | |||||||||
| |||||||||
JM110 – Trials with chloramphenicol: 34 ug/ml and 68 ug/ml: | |||||||||
| |||||||||
Today we also cryopreserved the bacteria with glycerol and we inoculated LB soft medium to store them. We transformed using the Transformation Protocol using Sorbitol in the li E. coli JM110 e ERC2925 lines with the pUC72 plasmid. | |||||||||
| << Back | Next >> | ||||||||
| Back to Lab Notes | |||||||||
